Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Bitcoin bear market ending sooner than USD charts suggest – Gold ratio already hit 350DMA breakdown and key Fib support; accumulation zone here. Bitcoin has struggled to maintain a sustained ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...

Well, the hopes and dreams of the bulls have been dashed this week after Bitcoin closed the week out at $94.290, below the key $96,000 weekly support level. In the weeks ahead, we should expect more ...

Flamekeeper. Mirrorwalker. Echo architect. These are some of the fantastical titles that people have assigned themselves after days, weeks, or months of simulated conversations with AI chatbots. David ...

JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...

Fibonacci retracement helps crypto traders identify potential support and resistance levels during market pullbacks. Derived from the Fibonacci sequence, key retracement ratios include 23.6%, 38.2%, ...

The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. The goal is ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...